Search Results

Mavatrep 5mg 5mg  | Purity Not Available

Adooq Bioscience

Mavatrep is an orally bioavailable TRPV1 antagonist (Ki=6.5 nM), exhibits minimal effect on the enzymatic activity (IC50 > 25 ??M) of CYP isoforms 3A4, 1A2, and 2D6.

More Information Supplier Page

Mavatrep 2mg 2mg  | Purity Not Available

Adooq Bioscience

Mavatrep is an orally bioavailable TRPV1 antagonist (Ki=6.5 nM), exhibits minimal effect on the enzymatic activity (IC50 > 25 ??M) of CYP isoforms 3A4, 1A2, and 2D6.

More Information Supplier Page

Mavatrep 10mg 10mg  | Purity Not Available

Adooq Bioscience

Mavatrep is an orally bioavailable TRPV1 antagonist (Ki=6.5 nM), exhibits minimal effect on the enzymatic activity (IC50 > 25 ??M) of CYP isoforms 3A4, 1A2, and 2D6.

More Information Supplier Page

JH-II-127 5mg 5mg  | Purity Not Available

Adooq Bioscience

JH-II-127 is a highly potent, selective, and brain penetrant LRRK2 inhibitor, with IC50 of 6.6 nM, 2.2 nM ,47.7 nM for LRRK2-wild-type, LRRK2-G2019S, LRRK2-A2016T.

More Information Supplier Page

JH-II-127 25mg 25mg  | Purity Not Available

Adooq Bioscience

JH-II-127 is a highly potent, selective, and brain penetrant LRRK2 inhibitor, with IC50 of 6.6 nM, 2.2 nM ,47.7 nM for LRRK2-wild-type, LRRK2-G2019S, LRRK2-A2016T.

More Information Supplier Page

JH-II-127 10mg 10mg  | Purity Not Available

Adooq Bioscience

JH-II-127 is a highly potent, selective, and brain penetrant LRRK2 inhibitor, with IC50 of 6.6 nM, 2.2 nM ,47.7 nM for LRRK2-wild-type, LRRK2-G2019S, LRRK2-A2016T.

More Information Supplier Page

WST-8 100mg 100mg  | Purity Not Available

Adooq Bioscience

WST-8 is a next generation tetrazolium reagent that serves as a sensitive chromogenic indicator for NADH.

More Information Supplier Page